Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Henn

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Virology|September 2, 2011
Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymeraseCesar Oniangue-Ndza, Thomas Kuntzen, Michael Kemper, et al.
Environmental Microbiology|July 29, 2010
Genomic analysis of oceanic cyanobacterial myoviruses compared with T4-like myoviruses from diverse hosts and environmentsMatthew B Sullivan, Katherine H Huang, Julio C Ignacio-Espinoza, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Nature Medicine|April 11, 2025
Clinical translation of microbiome researchJack A Gilbert, Meghan B Azad, Fredrik Bäckhed, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 4, 2011
A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutationD J Schmidt, B E Pickett, D Camacho, et al.
Nature Medicine|January 6, 2026
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiomeJessica A Bryant, Marin Vulić, Emily A Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
Genome Biology|February 9, 2010
A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454Niall J Lennon, Robert E Lintner, Scott Anderson, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Virology|September 2, 2011
Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymeraseCesar Oniangue-Ndza, Thomas Kuntzen, Michael Kemper, et al.
Environmental Microbiology|July 29, 2010
Genomic analysis of oceanic cyanobacterial myoviruses compared with T4-like myoviruses from diverse hosts and environmentsMatthew B Sullivan, Katherine H Huang, Julio C Ignacio-Espinoza, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.
Gastroenterology|August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative ColitisMatthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Nature Medicine|April 11, 2025
Clinical translation of microbiome researchJack A Gilbert, Meghan B Azad, Fredrik Bäckhed, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 4, 2011
A phylogenetic analysis using full-length viral genomes of South American dengue serotype 3 in consecutive Venezuelan outbreaks reveals a novel NS5 mutationD J Schmidt, B E Pickett, D Camacho, et al.
Nature Medicine|January 6, 2026
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiomeJessica A Bryant, Marin Vulić, Emily A Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
Genome Biology|February 9, 2010
A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454Niall J Lennon, Robert E Lintner, Scott Anderson, et al.
Pageof 12